Voice your opinion on congressional bill HR1092-118 and let lawmakers know your stance with UnPac!

Main Subject: Health

Better Empowerment Now to Enhance Framework and Improve Treatments Act of 2023 or the BENEFIT Act of 2023

This bill requires the Food and Drug Administration (FDA) to consider relevant patient experience data in the risk-benefit assessment framework used in the process for approving new drugs.

After a new drug application has been approved, the FDA's public statement about how it used patient experience data shall include a description of how such data was considered in the risk-benefit assessment framework.

House committee actions Actions

Committee
Feb. 24 2023	Referred to the Subcommittee on Health.

House floor actions Actions

IntroReferral
Feb. 17 2023	Referred to the House Committee on Energy and Commerce.

Library of Congress Actions

IntroReferral
Feb. 17 2023	Introduced in House Introduced in House

House bill HR1092-118

BENEFIT Act of 2023

House bill HR1092-118

BENEFIT Act of 2023

Promote the cause!

Or use this QR code